{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:24:08Z","timestamp":1793643848970,"version":"4.5.1"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Struct Mol Biol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1038\/s41594-025-01537-1","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T05:02:30Z","timestamp":1745816550000},"page":"1825-1837","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Design of PROTACs utilizing the E3 ligase GID4 for targeted protein degradation"],"prefix":"10.1038","volume":"32","author":[{"given":"Yanran","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiwen","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyue","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixin","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojie","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengying","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinzhi","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3131-7804","authenticated-orcid":false,"given":"Jun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7453-051X","authenticated-orcid":false,"given":"Wenyi","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3195-6948","authenticated-orcid":false,"given":"Songbo","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0046-9741","authenticated-orcid":false,"given":"Dongxing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1679-3618","authenticated-orcid":false,"given":"Lei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2891-8759","authenticated-orcid":false,"given":"Cheng","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"key":"1537_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-021-00371-6","author":"M Bekes","year":"2022","unstructured":"Bekes, M., Langley, D. R. & Crews, C. M. PROTAC targeted protein degraders: the past is prologue. Nat. Rev. Drug Discov. https:\/\/doi.org\/10.1038\/s41573-021-00371-6 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1537_CR2","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/s41568-021-00365-x","volume":"21","author":"B Dale","year":"2021","unstructured":"Dale, B. et al. Advancing targeted protein degradation for cancer therapy. Nat. Rev. Cancer 21, 638\u2013654 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"1537_CR3","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/d41586-019-00879-3","volume":"567","author":"M Scudellari","year":"2019","unstructured":"Scudellari, M. Protein-slaying drugs could be the next blockbuster therapies. Nature 567, 298\u2013300 (2019).","journal-title":"Nature"},{"key":"1537_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/d41573-019-00043-6","author":"A Mullard","year":"2019","unstructured":"Mullard, A. First targeted protein degrader hits the clinic. Nat. Rev. Drug Discov. https:\/\/doi.org\/10.1038\/d41573-019-00043-6 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1537_CR5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41392-022-00999-9","volume":"7","author":"M He","year":"2022","unstructured":"He, M. et al. PROTACs: great opportunities for academia and industry (an update from 2020 to 2021). Signal Transduct. Target Ther. 7, 181 (2022).","journal-title":"Signal Transduct. Target Ther."},{"key":"1537_CR6","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41571-023-00736-3","volume":"20","author":"D Chirnomas","year":"2023","unstructured":"Chirnomas, D., Hornberger, K. R. & Crews, C. M. Protein degraders enter the clinic\u2014a new approach to cancer therapy. Nat. Rev. Clin. Oncol. 20, 265\u2013278 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1537_CR7","doi-asserted-by":"publisher","first-page":"8554","DOI":"10.1073\/pnas.141230798","volume":"98","author":"KM Sakamoto","year":"2001","unstructured":"Sakamoto, K. M. et al. Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation. Proc. Natl Acad. Sci. USA 98, 8554\u20138559 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1537_CR8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.chembiol.2017.09.009","volume":"25","author":"GM Burslem","year":"2018","unstructured":"Burslem, G. M. et al. The advantages of targeted protein degradation over inhibition: an RTK case study. Cell Chem. Biol. 25, 67\u201377 e63 (2018).","journal-title":"Cell Chem. Biol."},{"key":"1537_CR9","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrd.2016.211","volume":"16","author":"AC Lai","year":"2017","unstructured":"Lai, A. C. & Crews, C. M. Induced protein degradation: an emerging drug discovery paradigm. Nat. Rev. Drug Discov. 16, 101\u2013114 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1537_CR10","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41573-021-00199-0","volume":"20","author":"MJ Henley","year":"2021","unstructured":"Henley, M. J. & Koehler, A. N. Advances in targeting \u2018undruggable\u2019 transcription factors with small molecules. Nat. Rev. Drug Discov. 20, 669\u2013688 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1537_CR11","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.ccell.2019.10.002","volume":"36","author":"L Bai","year":"2019","unstructured":"Bai, L. et al. A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo. Cancer Cell 36, 498\u2013511 e417 (2019).","journal-title":"Cancer Cell"},{"key":"1537_CR12","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nchembio.1858","volume":"11","author":"DP Bondeson","year":"2015","unstructured":"Bondeson, D. P. et al. Catalytic in vivo protein knockdown by small-molecule PROTACs. Nat. Chem. Biol. 11, 611\u2013617 (2015).","journal-title":"Nat. Chem. Biol."},{"key":"1537_CR13","doi-asserted-by":"publisher","first-page":"D1367","DOI":"10.1093\/nar\/gkac946","volume":"51","author":"G Weng","year":"2023","unstructured":"Weng, G. et al. PROTAC-DB 2.0: an updated database of PROTACs. Nucleic Acids Res. 51, D1367\u2013D1372 (2023).","journal-title":"Nucleic Acids Res."},{"key":"1537_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-019-0047-y","author":"M Schapira","year":"2019","unstructured":"Schapira, M., Calabrese, M. F., Bullock, A. N. & Crews, C. M. Targeted protein degradation: expanding the toolbox. Nat. Rev. Drug Discov. https:\/\/doi.org\/10.1038\/s41573-019-0047-y (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1537_CR15","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1126\/science.aab1433","volume":"348","author":"GE Winter","year":"2015","unstructured":"Winter, G. E. et al. DRUG DEVELOPMENT. Phthalimide conjugation as a strategy for in vivo target protein degradation. Science 348, 1376\u20131381 (2015).","journal-title":"Science"},{"key":"1537_CR16","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.chembiol.2015.05.009","volume":"22","author":"J Lu","year":"2015","unstructured":"Lu, J. et al. Hijacking the E3 ubiquitin ligase cereblon to efficiently target BRD4. Chem. Biol. 22, 755\u2013763 (2015).","journal-title":"Chem. Biol."},{"key":"1537_CR17","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1021\/acschembio.5b00216","volume":"10","author":"M Zengerle","year":"2015","unstructured":"Zengerle, M., Chan, K. H. & Ciulli, A. Selective small molecule induced degradation of the BET bromodomain protein BRD4. ACS Chem. Biol. 10, 1770\u20131777 (2015).","journal-title":"ACS Chem. Biol."},{"key":"1537_CR18","doi-asserted-by":"publisher","DOI":"10.1177\/2472555220965528","author":"T Ishida","year":"2020","unstructured":"Ishida, T. & Ciulli, A. E3 ligase ligands for PROTACs: how they were found and how to discover new ones. SLAS Discov. https:\/\/doi.org\/10.1177\/2472555220965528 (2020).","journal-title":"SLAS Discov."},{"key":"1537_CR19","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1039\/C8CC09541H","volume":"55","author":"C Steinebach","year":"2019","unstructured":"Steinebach, C. et al. PROTAC-mediated crosstalk between E3 ligases. Chem. Commun. 55, 1821\u20131824 (2019).","journal-title":"Chem. Commun."},{"key":"1537_CR20","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1016\/j.bmc.2019.02.048","volume":"27","author":"M Girardini","year":"2019","unstructured":"Girardini, M., Maniaci, C., Hughes, S. J., Testa, A. & Ciulli, A. Cereblon versus VHL: hijacking E3 ligases against each other using PROTACs. Bioorg. Med. Chem. 27, 2466\u20132479 (2019).","journal-title":"Bioorg. Med. Chem."},{"key":"1537_CR21","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/anie.201507634","volume":"55","author":"AC Lai","year":"2016","unstructured":"Lai, A. C. et al. Modular PROTAC design for the degradation of oncogenic BCR-ABL. Angew. Chem. 55, 807\u2013810 (2016).","journal-title":"Angew. Chem."},{"key":"1537_CR22","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1016\/j.cell.2020.10.038","volume":"183","author":"KA Donovan","year":"2020","unstructured":"Donovan, K. A. et al. Mapping the degradable kinome provides a resource for expedited degrader development. Cell 183, 1714\u20131731 e1710 (2020).","journal-title":"Cell"},{"key":"1537_CR23","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.chembiol.2017.09.010","volume":"25","author":"DP Bondeson","year":"2018","unstructured":"Bondeson, D. P. et al. Lessons in PROTAC design from selective degradation with a promiscuous warhead. Cell Chem. Biol. 25, 78\u201387 e75 (2018).","journal-title":"Cell Chem. Biol."},{"key":"1537_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.103985","volume":"25","author":"X Luo","year":"2022","unstructured":"Luo, X. et al. Profiling of diverse tumor types establishes the broad utility of VHL-based ProTaCs and triages candidate ubiquitin ligases. iScience 25, 103985 (2022).","journal-title":"iScience"},{"key":"1537_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108532","volume":"34","author":"R Shirasaki","year":"2021","unstructured":"Shirasaki, R. et al. Functional genomics identify distinct and overlapping genes mediating resistance to different classes of heterobifunctional degraders of oncoproteins. Cell Rep. 34, 108532 (2021).","journal-title":"Cell Rep."},{"key":"1537_CR26","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1158\/1535-7163.MCT-18-1129","volume":"18","author":"L Zhang","year":"2019","unstructured":"Zhang, L., Riley-Gillis, B., Vijay, P. & Shen, Y. Acquired resistance to BET-PROTACs (proteolysis-targeting chimeras) caused by genomic alterations in core components of E3 ligase complexes. Mol. Cancer Ther. 18, 1302\u20131311 (2019).","journal-title":"Mol. Cancer Ther."},{"key":"1537_CR27","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41589-022-01177-2","volume":"19","author":"A Hanzl","year":"2023","unstructured":"Hanzl, A. et al. Functional E3 ligase hotspots and resistance mechanisms to small-molecule degraders. Nat. Chem. Biol. 19, 323\u2013333 (2023).","journal-title":"Nat. Chem. Biol."},{"key":"1537_CR28","doi-asserted-by":"publisher","first-page":"6515","DOI":"10.3390\/molecules27196515","volume":"27","author":"J Lee","year":"2022","unstructured":"Lee, J. et al. Discovery of E3 ligase ligands for target protein degradation. Molecules 27, 6515 (2022).","journal-title":"Molecules"},{"key":"1537_CR29","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.gene.2007.02.032","volume":"396","author":"N Kobayashi","year":"2007","unstructured":"Kobayashi, N. et al. RanBPM, Muskelin, p48EMLP, p44CTLH, and the armadillo-repeat proteins ARMC8alpha and ARMC8beta are components of the CTLH complex. Gene 396, 236\u2013247 (2007).","journal-title":"Gene"},{"key":"1537_CR30","doi-asserted-by":"publisher","first-page":"e75217","DOI":"10.1371\/journal.pone.0075217","volume":"8","author":"O Francis","year":"2013","unstructured":"Francis, O., Han, F. & Adams, J. C. Molecular phylogeny of a RING E3 ubiquitin ligase, conserved in eukaryotic cells and dominated by homologous components, the muskelin\/RanBPM\/CTLH complex. PLoS ONE 8, e75217 (2013).","journal-title":"PLoS ONE"},{"key":"1537_CR31","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1091\/mbc.e08-03-0328","volume":"19","author":"O Santt","year":"2008","unstructured":"Santt, O. et al. The yeast GID complex, a novel ubiquitin ligase (E3) involved in the regulation of carbohydrate metabolism. Mol. Biol. Cell 19, 3323\u20133333 (2008).","journal-title":"Mol. Biol. Cell"},{"key":"1537_CR32","doi-asserted-by":"publisher","first-page":"25602","DOI":"10.1074\/jbc.M112.363762","volume":"287","author":"R Menssen","year":"2012","unstructured":"Menssen, R. et al. Exploring the topology of the GID complex, the E3 ubiquitin ligase involved in catabolite-induced degradation of gluconeogenic enzymes. J. Biol. Chem. 287, 25602\u201325614 (2012).","journal-title":"J. Biol. Chem."},{"key":"1537_CR33","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1515\/hsz-2019-0139","volume":"400","author":"H Liu","year":"2019","unstructured":"Liu, H. & Pfirrmann, T. The GID-complex: an emerging player in the ubiquitin ligase league. Biol. Chem. 400, 1429\u20131441 (2019).","journal-title":"Biol. Chem."},{"key":"1537_CR34","doi-asserted-by":"publisher","first-page":"5863","DOI":"10.3390\/ijms23115863","volume":"23","author":"MER Maitland","year":"2022","unstructured":"Maitland, M. E. R., Lajoie, G. A., Shaw, G. S. & Schild-Poulter, C. Structural and functional insights into GID\/CTLH E3 ligase complexes. Int. J. Mol. Sci. 23, 5863 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"1537_CR35","doi-asserted-by":"publisher","first-page":"4216750","DOI":"10.1155\/2019\/4216750","volume":"2019","author":"N Huffman","year":"2019","unstructured":"Huffman, N., Palmieri, D. & Coppola, V. The CTLH complex in cancer cell plasticity. J. Oncol. 2019, 4216750 (2019).","journal-title":"J. Oncol."},{"key":"1537_CR36","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1016\/j.molcel.2024.04.026","volume":"84","author":"SA Yi","year":"2024","unstructured":"Yi, S. A., Sepic, S., Schulman, B. A., Ordureau, A. & An, H. mTORC1-CTLH E3 ligase regulates the degradation of HMG-CoA synthase 1 through the Pro\/N-degron pathway. Mol. Cell 84, 2166\u20132184.e9 (2024).","journal-title":"Mol. Cell"},{"key":"1537_CR37","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1016\/j.molcel.2024.04.014","volume":"84","author":"KV Gottemukkala","year":"2024","unstructured":"Gottemukkala, K. V. et al. Non-canonical substrate recognition by the human WDR26-CTLH E3 ligase regulates prodrug metabolism. Mol. Cell 84, 1948\u20131963 e1911 (2024).","journal-title":"Mol. Cell"},{"key":"1537_CR38","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1073\/pnas.1816596116","volume":"116","author":"A Varshavsky","year":"2019","unstructured":"Varshavsky, A. N-degron and C-degron pathways of protein degradation. Proc. Natl Acad. Sci. USA 116, 358\u2013366 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1537_CR39","doi-asserted-by":"publisher","first-page":"eaal3655","DOI":"10.1126\/science.aal3655","volume":"355","author":"SJ Chen","year":"2017","unstructured":"Chen, S. J., Wu, X., Wadas, B., Oh, J. H. & Varshavsky, A. An N-end rule pathway that recognizes proline and destroys gluconeogenic enzymes. Science 355, eaal3655 (2017).","journal-title":"Science"},{"key":"1537_CR40","doi-asserted-by":"publisher","first-page":"e2115430118","DOI":"10.1073\/pnas.2115430118","volume":"118","author":"SJ Chen","year":"2021","unstructured":"Chen, S. J., Kim, L., Song, H. K. & Varshavsky, A. Aminopeptidases trim Xaa-Pro proteins, initiating their degradation by the Pro\/N-degron pathway. Proc. Natl Acad. Sci. USA 118, e2115430118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1537_CR41","doi-asserted-by":"publisher","first-page":"14158","DOI":"10.1073\/pnas.2007085117","volume":"117","author":"C Dong","year":"2020","unstructured":"Dong, C. et al. Recognition of nonproline N-terminal residues by the Pro\/N-degron pathway. Proc. Natl Acad. Sci. USA 117, 14158\u201314167 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1537_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2021.167347","volume":"434","author":"J Chrustowicz","year":"2022","unstructured":"Chrustowicz, J. et al. Multifaceted N-degron recognition and ubiquitylation by GID\/CTLH E3 ligases. J. Mol. Biol. 434, 167347 (2022).","journal-title":"J. Mol. Biol."},{"key":"1537_CR43","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/s41589-018-0036-1","volume":"14","author":"C Dong","year":"2018","unstructured":"Dong, C. et al. Molecular basis of GID4-mediated recognition of degrons for the Pro\/N-end rule pathway. Nat. Chem. Biol. 14, 466\u2013473 (2018).","journal-title":"Nat. Chem. Biol."},{"key":"1537_CR44","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.molcel.2019.10.009","volume":"77","author":"S Qiao","year":"2020","unstructured":"Qiao, S. et al. Interconversion between anticipatory and active GID E3 ubiquitin ligase conformations via metabolically driven substrate receptor assembly. Mol. Cell 77, 150\u2013163 e159 (2020).","journal-title":"Mol. Cell"},{"key":"1537_CR45","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1016\/j.molcel.2021.04.018","volume":"81","author":"KE Kong","year":"2021","unstructured":"Kong, K. E. et al. Timer-based proteomic profiling of the ubiquitin-proteasome system reveals a substrate receptor of the GID ubiquitin ligase. Mol. Cell 81, 2460\u20132476.e11 (2021).","journal-title":"Mol. Cell"},{"key":"1537_CR46","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202152981","volume":"22","author":"WI Mohamed","year":"2021","unstructured":"Mohamed, W. I. et al. The human GID complex engages two independent modules for substrate recruitment. EMBO Rep. 22, e52981 (2021).","journal-title":"EMBO Rep."},{"key":"1537_CR47","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1016\/j.molcel.2021.03.025","volume":"81","author":"D Sherpa","year":"2021","unstructured":"Sherpa, D. et al. GID E3 ligase supramolecular chelate assembly configures multipronged ubiquitin targeting of an oligomeric metabolic enzyme. Mol. Cell 81, 2445\u20132459 e2413 (2021).","journal-title":"Mol. Cell"},{"key":"1537_CR48","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.molcel.2023.11.027","volume":"84","author":"J Chrustowicz","year":"2024","unstructured":"Chrustowicz, J. et al. Multisite phosphorylation dictates selective E2-E3 pairing as revealed by Ubc8\/UBE2H-GID\/CTLH assemblies. Mol. Cell 84, 293\u2013308 e214 (2024).","journal-title":"Mol. Cell"},{"key":"1537_CR49","doi-asserted-by":"publisher","DOI":"10.1039\/D3MD00633F","author":"AK Yazdi","year":"2024","unstructured":"Yazdi, A. K. et al. Chemical tools for the Gid4 subunit of the human E3 ligase C-terminal to LisH (CTLH) degradation complex. RSC Med. Chem. https:\/\/doi.org\/10.1039\/D3MD00633F (2024).","journal-title":"RSC Med. Chem."},{"key":"1537_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41589-024-01618-0","author":"DDG Owens","year":"2024","unstructured":"Owens, D. D. G. et al. A chemical probe to modulate human GID4 Pro\/N-degron interactions. Nat. Chem. Biol. https:\/\/doi.org\/10.1038\/s41589-024-01618-0 (2024).","journal-title":"Nat. Chem. Biol."},{"key":"1537_CR51","doi-asserted-by":"publisher","first-page":"12725","DOI":"10.1021\/acs.jmedchem.2c00509","volume":"65","author":"CK Chana","year":"2022","unstructured":"Chana, C. K. et al. Discovery and structural characterization of small molecule binders of the human CTLH E3 ligase subunit GID4. J. Med. Chem. 65, 12725\u201312746 (2022).","journal-title":"J. Med. Chem."},{"key":"1537_CR52","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s41589-018-0055-y","volume":"14","author":"RP Nowak","year":"2018","unstructured":"Nowak, R. P. et al. Plasticity in binding confers selectivity in ligand-induced protein degradation. Nat. Chem. Biol. 14, 706\u2013714 (2018).","journal-title":"Nat. Chem. Biol."},{"key":"1537_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41594-023-01146-w","author":"CM Hickey","year":"2024","unstructured":"Hickey, C. M. et al. Co-opting the E3 ligase KLHDC2 for targeted protein degradation by small molecules. Nat. Struct. Mol. Biol. https:\/\/doi.org\/10.1038\/s41594-023-01146-w (2024).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1537_CR54","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/nature09504","volume":"468","author":"P Filippakopoulos","year":"2010","unstructured":"Filippakopoulos, P. et al. Selective inhibition of BET bromodomains. Nature 468, 1067\u20131073 (2010).","journal-title":"Nature"},{"key":"1537_CR55","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.cell.2012.02.013","volume":"149","author":"P Filippakopoulos","year":"2012","unstructured":"Filippakopoulos, P. et al. Histone recognition and large-scale structural analysis of the human bromodomain family. Cell 149, 214\u2013231 (2012).","journal-title":"Cell"},{"key":"1537_CR56","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/nchembio.2329","volume":"13","author":"MS Gadd","year":"2017","unstructured":"Gadd, M. S. et al. Structural basis of PROTAC cooperative recognition for selective protein degradation. Nat. Chem. Biol. 13, 514\u2013521 (2017).","journal-title":"Nat. Chem. Biol."},{"key":"1537_CR57","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41589-020-00686-2","volume":"17","author":"J Schiemer","year":"2021","unstructured":"Schiemer, J. et al. Snapshots and ensembles of BTK and cIAP1 protein degrader ternary complexes. Nat. Chem. Biol. 17, 152\u2013160 (2021).","journal-title":"Nat. Chem. Biol."},{"key":"1537_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54500-x","volume":"15","author":"MF Mabanglo","year":"2024","unstructured":"Mabanglo, M. F. et al. Crystal structures of DCAF1-PROTAC-WDR5 ternary complexes provide insight into DCAF1 substrate specificity. Nat. Commun. 15, 10165 (2024).","journal-title":"Nat. Commun."},{"key":"1537_CR59","doi-asserted-by":"publisher","first-page":"9370","DOI":"10.1021\/jm500670d","volume":"57","author":"NM O\u2019Boyle","year":"2014","unstructured":"O\u2019Boyle, N. M. et al. beta-Lactam estrogen receptor antagonists and a dual-targeting estrogen receptor\/tubulin ligand. J. Med. Chem. 57, 9370\u20139382 (2014).","journal-title":"J. Med. Chem."},{"key":"1537_CR60","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41589-019-0294-6","volume":"15","author":"W Farnaby","year":"2019","unstructured":"Farnaby, W. et al. BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design. Nat. Chem. Biol. 15, 672\u2013680 (2019).","journal-title":"Nat. Chem. Biol."},{"key":"1537_CR61","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/978-1-0716-1665-9_5","volume":"2365","author":"R Casement","year":"2021","unstructured":"Casement, R., Bond, A., Craigon, C. & Ciulli, A. Mechanistic and structural features of PROTAC ternary complexes. Methods Mol. Biol. 2365, 79\u2013113 (2021).","journal-title":"Methods Mol. Biol."},{"key":"1537_CR62","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1021\/acschembio.0c00266","volume":"15","author":"CW Chung","year":"2020","unstructured":"Chung, C. W. et al. Structural insights into PROTAC-mediated degradation of Bcl-xL. ACS Chem. Biol. 15, 2316\u20132323 (2020).","journal-title":"ACS Chem. Biol."},{"key":"1537_CR63","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1002\/anie.201914396","volume":"59","author":"A Testa","year":"2020","unstructured":"Testa, A., Hughes, S. J., Lucas, X., Wright, J. E. & Ciulli, A. Structure-based design of a macrocyclic PROTAC. Angew. Chem. 59, 1727\u20131734 (2020).","journal-title":"Angew. Chem."},{"key":"1537_CR64","doi-asserted-by":"publisher","first-page":"23327","DOI":"10.1002\/anie.202109237","volume":"60","author":"RP Law","year":"2021","unstructured":"Law, R. P. et al. Discovery and characterisation of highly cooperative FAK-degrading PROTACs. Angew. Chem. 60, 23327\u201323334 (2021).","journal-title":"Angew. Chem."},{"key":"1537_CR65","doi-asserted-by":"publisher","first-page":"eabj1578","DOI":"10.1126\/scitranslmed.abj1578","volume":"13","author":"X Yu","year":"2021","unstructured":"Yu, X. et al. A selective WDR5 degrader inhibits acute myeloid leukemia in patient-derived mouse models. Sci. Transl. Med. 13, eabj1578 (2021).","journal-title":"Sci. Transl. Med."},{"key":"1537_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33430-6","volume":"13","author":"C Kofink","year":"2022","unstructured":"Kofink, C. et al. A selective and orally bioavailable VHL-recruiting PROTAC achieves SMARCA2 degradation in vivo. Nat. Commun. 13, 5969 (2022).","journal-title":"Nat. Commun."},{"key":"1537_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46922-4","volume":"15","author":"D Nayak","year":"2024","unstructured":"Nayak, D. et al. Development and crystal structures of a potent second-generation dual degrader of BCL-2 and BCL-xL. Nat. Commun. 15, 2743 (2024).","journal-title":"Nat. Commun."},{"key":"1537_CR68","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1126\/science.3018930","volume":"234","author":"A Bachmair","year":"1986","unstructured":"Bachmair, A., Finley, D. & Varshavsky, A. In vivo half-life of a protein is a function of its amino-terminal residue. Science 234, 179\u2013186 (1986).","journal-title":"Science"},{"key":"1537_CR69","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/j.cell.2018.04.028","volume":"173","author":"I Koren","year":"2018","unstructured":"Koren, I. et al. The eukaryotic proteome is shaped by E3 ubiquitin ligases targeting C-terminal degrons. Cell 173, 1622\u20131635 e1614 (2018).","journal-title":"Cell"},{"key":"1537_CR70","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.molcel.2018.04.006","volume":"70","author":"HC Lin","year":"2018","unstructured":"Lin, H. C. et al. C-terminal end-directed protein elimination by CRL2 ubiquitin ligases. Mol. Cell 70, 602\u2013613 e603 (2018).","journal-title":"Mol. Cell"},{"key":"1537_CR71","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1016\/j.molcel.2022.02.004","volume":"82","author":"D Sherpa","year":"2022","unstructured":"Sherpa, D., Chrustowicz, J. & Schulman, B. A. How the ends signal the end: regulation by E3 ubiquitin ligases recognizing protein termini. Mol. Cell 82, 1424\u20131438 (2022).","journal-title":"Mol. Cell"},{"key":"1537_CR72","doi-asserted-by":"publisher","first-page":"eaaw4912","DOI":"10.1126\/science.aaw4912","volume":"365","author":"RT Timms","year":"2019","unstructured":"Timms, R. T. et al. A glycine-specific N-degron pathway mediates the quality control of protein N-myristoylation. Science 365, eaaw4912 (2019).","journal-title":"Science"},{"key":"1537_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2021.06.010","author":"X Yan","year":"2021","unstructured":"Yan, X. et al. Molecular basis for recognition of Gly\/N-degrons by CRL2(ZYG11B) and CRL2(ZER1). Mol. Cell https:\/\/doi.org\/10.1016\/j.molcel.2021.06.010 (2021).","journal-title":"Mol. Cell"},{"key":"1537_CR74","doi-asserted-by":"publisher","first-page":"e2408697121","DOI":"10.1073\/pnas.2408697121","volume":"121","author":"A Varshavsky","year":"2024","unstructured":"Varshavsky, A. N-degron pathways. Proc. Natl Acad. Sci. USA 121, e2408697121 (2024).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1537_CR75","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.4c00208","author":"J Zhang","year":"2024","unstructured":"Zhang, J. et al. Distinct amino acid-based PROTACs target oncogenic kinases for degradation in non-small cell lung cancer (NSCLC). J. Med. Chem. https:\/\/doi.org\/10.1021\/acs.jmedchem.4c00208 (2024).","journal-title":"J. Med. Chem."},{"key":"1537_CR76","doi-asserted-by":"publisher","first-page":"17548","DOI":"10.1002\/anie.202005004","volume":"59","author":"Y Lee","year":"2020","unstructured":"Lee, Y. et al. Targeted degradation of transcription coactivator SRC-1 through the N-degron pathway. Angew. Chem. 59, 17548\u201317555 (2020).","journal-title":"Angew. Chem."},{"key":"1537_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2023.07.006","author":"S Roth","year":"2023","unstructured":"Roth, S. et al. Identification of KLHDC2 as an efficient proximity-induced degrader of K-RAS, STK33, beta-catenin, and FoxP3. Cell Chem. Biol. https:\/\/doi.org\/10.1016\/j.chembiol.2023.07.006 (2023).","journal-title":"Cell Chem. Biol."},{"key":"1537_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2023.07.008","author":"Y Kim","year":"2023","unstructured":"Kim, Y. et al. Targeted kinase degradation via the KLHDC2 ubiquitin E3 ligase. Cell Chem. Biol. https:\/\/doi.org\/10.1016\/j.chembiol.2023.07.008 (2023).","journal-title":"Cell Chem. Biol."},{"key":"1537_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52966-3","volume":"15","author":"DC Scott","year":"2024","unstructured":"Scott, D. C. et al. Principles of paralog-specific targeted protein degradation engaging the C-degron E3 KLHDC2. Nat. Commun. 15, 8829 (2024).","journal-title":"Nat. Commun."},{"key":"1537_CR80","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1021\/jacs.1c03980","volume":"144","author":"NJ Henning","year":"2022","unstructured":"Henning, N. J. et al. Discovery of a covalent FEM1B recruiter for targeted protein degradation applications. J. Am. Chem. Soc. 144, 701\u2013708 (2022).","journal-title":"J. Am. Chem. Soc."},{"key":"1537_CR81","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1107\/S0907444909047337","volume":"66","author":"W Kabsch","year":"2010","unstructured":"Kabsch, W. XDS. Acta Crystallogr. D 66, 125\u2013132 (2010).","journal-title":"Acta Crystallogr. D"},{"key":"1537_CR82","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1107\/S2059798319011471","volume":"75","author":"D Liebschner","year":"2019","unstructured":"Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr. D 75, 861\u2013877 (2019).","journal-title":"Acta Crystallogr. D"},{"key":"1537_CR83","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of COOT. Acta Crystallogr. D 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D"},{"key":"1537_CR84","doi-asserted-by":"publisher","first-page":"D1211","DOI":"10.1093\/nar\/gky869","volume":"47","author":"J Ma","year":"2019","unstructured":"Ma, J. et al. iProX: an integrated proteome resource. Nucleic Acids Res. 47, D1211\u2013D1217 (2019).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Structural & Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41594-025-01537-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41594-025-01537-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41594-025-01537-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T21:03:41Z","timestamp":1758056621000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41594-025-01537-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":84,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["1537"],"URL":"https:\/\/doi.org\/10.1038\/s41594-025-01537-1","relation":{},"ISSN":["1545-9993","1545-9985"],"issn-type":[{"value":"1545-9993","type":"print"},{"value":"1545-9985","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,28]]},"assertion":[{"value":"31 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.D., L.S., D.C., J.S. and Y.L. declare the filing of a patent application covering the PROTACs described in this paper. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}